Literature DB >> 21844453

Clonal T-cell receptor β-chain gene rearrangements in differential diagnosis of lymphomatoid papulosis from skin metastasis of nodal anaplastic large-cell lymphoma.

Oleg E Akilov1, Raju K Pillai, Lisa M Grandinetti, Jeffrey A Kant, Larisa Geskin.   

Abstract

BACKGROUND: In patients with a history of nodal anaplastic large-cell lymphoma (ALCL), differentiation of type C lymphomatoid papulosis from cutaneous involvement of systemic ALCL may be challenging because the 2 entities may exhibit identical histologic features. Although metastatic ALCL generally carries the same clone as the primary lymphoma, expression of a distinct clone likely represents a distinct process. OBSERVATIONS: A 54-year-old white man had a history of anaplastic lymphoma kinase 1-negative ALCL in the right inguinal lymph node 6 years ago. A complete response was achieved after 6 cycles of CHOP (cyclophosphamide, doxorubicin, vincristine [Oncovin], and prednisone administered in 21-day cycles) and radiation therapy. After 3½ years, the patient observed waxing and waning papules and nodules. Examination of the biopsy specimen revealed a dense CD30(+) lymphocytic infiltrate; no evidence of systemic malignancy was evident on positron emission tomography. Although clinically the presentation was consistent with lymphomatoid papulosis, metastatic ALCL had to be excluded. Polymerase chain reaction analysis with T-cell receptor γ-chain gene rearrangement (TCR-γR) was performed on the original lymph node and new skin lesions. Results of the TCR-γR analysis were positive for clonality in both lesions. However, separate clonal processes were identified. The identification of distinct clones supported the clinical impression of lymphomatoid papulosis.
CONCLUSION: Polymerase chain reaction analysis of TCR-γR is a useful method for distinguishing different clonal processes and is recommended when differentiation of primary and secondary lymphoproliferative disorders is required.

Entities:  

Mesh:

Year:  2011        PMID: 21844453      PMCID: PMC3733445          DOI: 10.1001/archdermatol.2011.187

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  28 in total

Review 1.  Neoplastic stem cells in cutaneous lymphomas: evidence and clinical implications.

Authors:  Robert Gniadecki
Journal:  Arch Dermatol       Date:  2004-09

2.  The cell infiltrate in lymphomatoid papulosis comprises a mixture of polyclonal large atypical cells (CD30-positive) and smaller monoclonal T cells (CD30-negative).

Authors:  Sylke Gellrich; Martin Wernicke; Anke Wilks; Ansgar Lukowsky; J Marcus Muche; Kim Christian Jasch; Heike Audring; David Mason; Wolfram Sterry
Journal:  J Invest Dermatol       Date:  2004-03       Impact factor: 8.551

Review 3.  Analysis of clonality in cutaneous T cell lymphoma and associated diseases.

Authors:  G S Wood
Journal:  Ann N Y Acad Sci       Date:  2001-09       Impact factor: 5.691

4.  Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment.

Authors:  M W Bekkenk; F A Geelen; P C van Voorst Vader; F Heule; M L Geerts; W A van Vloten; C J Meijer; R Willemze
Journal:  Blood       Date:  2000-06-15       Impact factor: 22.113

5.  Successful treatment of a patient with lymphomatoid papulosis by methotrexate.

Authors:  N Yazawa; S Kondo; M Kagaya; H Yazawa; Y Minamitsuji; K Jimbow
Journal:  J Dermatol       Date:  2001-07       Impact factor: 4.005

6.  ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination.

Authors:  R L ten Berge; J J Oudejans; G J Ossenkoppele; K Pulford; R Willemze; B Falini; A Chott; C J Meijer
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

7.  A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases.

Authors:  Andrea Saggini; Andrea Gulia; Zsolt Argenyi; Regina Fink-Puches; Amelia Lissia; Mario Magaña; Luis Requena; Ingrid Simonitsch; Lorenzo Cerroni
Journal:  Am J Surg Pathol       Date:  2010-08       Impact factor: 6.394

8.  Lymphomatoid papulosis. Characterization of skin infiltrates by monoclonal antibodies.

Authors:  E Ralfkiaer; H Stein; G L Wantzin; K Thomsen; N Ralfkiaer; D Y Mason
Journal:  Am J Clin Pathol       Date:  1985-11       Impact factor: 2.493

9.  Single-cell analysis of CD30+ cells in lymphomatoid papulosis demonstrates a common clonal T-cell origin.

Authors:  Matthias Steinhoff; Michael Hummel; Ioannis Anagnostopoulos; Peter Kaudewitz; Volkhard Seitz; Chalid Assaf; Christian Sander; Harald Stein
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

Review 10.  Lymphomatoid papulosis.

Authors:  R Willemze
Journal:  Dermatol Clin       Date:  1985-10       Impact factor: 3.478

View more
  2 in total

Review 1.  Breast implant-associated ALCL: a unique entity in the spectrum of CD30+ lymphoproliferative disorders.

Authors:  Sara K Story; Michael K Schowalter; Larisa J Geskin
Journal:  Oncologist       Date:  2013-02-21

2.  CD30-positive cutaneous lymphoma: report of four cases with an emphasis on clinicopathological correlations.

Authors:  Thiago Jeunon de Sousa Vargas; Samira Barroso Jorge; Yung Bruno de Mello Gonzaga
Journal:  An Bras Dermatol       Date:  2017 Jan-Feb       Impact factor: 1.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.